利用体外靶点效率检测指导丹参SmPAL1基因的CRISPR/Cas9载体构建
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Directing construction of CRISPR/Cas9 vector of SmPAL1 in Salvia miltiorrhiza by target efficiency detection in vitro
  • 作者:邱镜仁 ; 苏钺凯 ; 宋振巧 ; 房信胜 ; 李景宇 ; 仉劲 ; 王建华
  • 英文作者:QIU Jing-ren;SU Yue-kai;SONG Zhen-qiao;FANG Xin-sheng;LI Jing-yu;ZHANG Jin;WANG Jian-hua;College of Agronomy, Shandong Agricultural University;
  • 关键词:丹参 ; 苯丙氨酸解氨酶 ; CRISPR/Cas9 ; 基因编辑 ; 靶点效率检测
  • 英文关键词:Salvia miltiorrhiza;;phenylalanine ammonia-lyase;;CRISPR/Cas9;;gene editing;;target efficienty detection
  • 中文刊名:ZGZY
  • 英文刊名:China Journal of Chinese Materia Medica
  • 机构:山东农业大学农学院;
  • 出版日期:2018-08-01 12:31
  • 出版单位:中国中药杂志
  • 年:2018
  • 期:v.43
  • 基金:山东省现代农业产业技术体系项目(SDAIT-20-04);; 山东省重点研发计划项目(2017CXGC1302,2016ZDJS07A22);; 国家重点研发计划项目(2017YFC1702705)
  • 语种:中文;
  • 页:ZGZY201821009
  • 页数:5
  • CN:21
  • ISSN:11-2272/R
  • 分类号:56-60
摘要
为定向编辑丹参苯丙烷代谢途径中关键酶基因SmPAL1构建CRISPR/Cas9载体,通过在线软件设计CIRSPR/Cas9靶位点,采用体外酶切法进行体外靶点效率检测,筛选活性高的序列,构建到CRISPR/Cas9载体中。设计了3个可能的CRISPR/Cas9靶位点(SmPAL1-g1,SmPAL1-g2,SmPAL1-g3),通过体外靶点效率检测,其活性分别为53.3%,76.6%,10.0%,将筛选出活性较高的2个靶位点SmPAL1-g1和SmPAL1-g2构建到载体VK005-03中并命名为VK005-03-g1和VK005-03-g2。测序结果显示,设计的2个CRISPR/Cas靶位点全部插入到VK005-03中,载体构建成功。
        To construct CRISPR/Cas9 vectors for the editing of SmPAL1 in the phenylpropane metabolic pathway of Salvia miltiorrhiza, CIRSPR/Cas9 target sites of SmPAL1 were designed by online software. Its target efficiencies were detected in vitro by enzyme digestion and sequences with highly efficiency were constructed into CRISPR/Cas9 vectors. Three possible CRISPR target sequences(SmPAL1-g1, SmPAL1-g2, SmPAL1-g3) were designed and the enzyme digestion efficiencies were 53.3%, 76.6% and 10.0%. SmPAL1-g1 and SmPAL1-g2 were constructed into vector VK005-03 named as VK005-03-g1 and VK005-03-g2. The results of sequencing showed that the two CRISPR/Cas target sequences were all constructed into VK005-03. Here we first laid the foundation for the study of SmPAL1 and provided an effective strategy for the screening of sgRNA.
引文
[1] Dong Y, Mirris-Natschke S L, Lee K H. Biosynthesis, total syntheses, and antitumor activity of tanshinones and their analogs as potential therapeutic agents[J]. Nat Prod Rep, 2011, 28(3): 529.
    [2] 曾明,邸晓辉,王金萍.注射用丹参多酚酸盐治疗缺血性脑卒中疗效与安全性的系统评价[J].中国实验方剂学杂志, 2015,21(5):225.
    [3] 朱艺平. 静脉滴注注射用丹参多酚酸盐致过敏性休克1例[J]. 中国现代应用药学, 2016, 33(9): 1213.
    [4] 宋经元,罗红梅,李春芳,等.丹参药用模式植物研究探讨[J].药学学报, 2013, 48 (7): 1099.
    [5] 曾慧婷,宿树兰,朱悦,等.丹参酚酸类成分生物合成途径及调控机制研究进展[J].中草药, 2016, 47(18): 3324.
    [6] 侯学敏.丹参迷迭香酸合成途径关键酶基因的鉴定与分析[D].临汾:山西师范大学,2013.
    [7] 谢胜松,张懿,张利生,等.CRISPR/Cas9系统中sgRNA设计与脱靶效应评估[J].遗传, 2015, 37(11): 1125.
    [8] 宗成堃,宋振巧,陈海梅,等.利用SSR、SRAP和ISSR分子标记构建首张丹参遗传连锁图谱[J].药学学报, 2015, 50(3): 360.
    [9] 陶洋,李金城,廖奇.CRISPR相关的生物信息学基础[J].中国生物化学与分子生物学报, 2016, 10(32):1067.
    [10] Xu H B, Song J Y, Luo H M, et al. Analysis of the genome sequence of the medicinal plant Salvia miltiorrhiza[J]. Mol Plant, 2016, 9(6): 949.
    [11] 左其生,王颖洁,赵瑞丰,等.CRISPR/Cas技术可有效介导家鸡基因敲除[J].畜牧兽医学报, 2016, 47(6): 1266.
    [12] Liu X, Wu S R, Xu J, et al. Application of CRISPR/Cas9 in plant biology[J]. Acta Pharm Sinica B, 2017; 7(3): 292.
    [13] 朱金洁.CRISPR-Cas9介导的玉米基因组定点编辑研究[D].北京:中国农业大学, 2015.
    [14] Liu T, Guo L L, Pan Y L, et al. Construction of the first highdensity genetic linkage map of Salvia miltiorrhiza using specific length amplified fragment (SLAF) sequencing[J]. Sci Rep, 2016, 6: 24070.
    [15] 叶兴国,杜丽璞.从转基因技术角度谈转基因植物的安全性[J].中国种业, 2016(9): 12.
    [16] Zhang G H, Tian Y, Zhang J,et al.Hybrid denovo genome assembly of the Chinese herbal plant danshen (Salvia miltiorrhiza Bunge)[J]. Giga Sci, 2015, 4: 62.